Ectopic expression of CGG-repeats alters ovarian response to gonadotropins and leads to infertility in a murine FMR1 premutation model
Authors:
Open Access
- 15 April 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 30 (10) , 923-938
Abstract
Women heterozygous for an expansion of CGG repeats in the 5’UTR of FMR1 risk developing fragile X-associated primary ovarian insufficiency (FXPOI) and/or tremor and ataxia syndrome (FXTAS). We show that expanded CGGs, independent of FMR1, are sufficient to drive ovarian insufficiency and that expression of CGG-containing mRNAs alone or in conjunction with a polyglycine-containing peptide translated from these RNAs contribute to dysfunction. Heterozygous females from two mouse lines expressing either CGG RNA-only (RNA-only) or CGG RNA and the polyglycine product FMRpolyG (FMRpolyG+RNA) were used to assess ovarian function in aging animals. The expression of FMRpolyG+RNA led to early cessation of breeding, ovulation and transcriptomic changes affecting cholesterol and steroid hormone biosynthesis. Females expressing CGG RNA-only did not exhibit decreased progeny during natural breeding, but their ovarian transcriptomes were enriched for alterations in cholesterol and lipid biosynthesis. The enrichment of CGG RNA-only ovaries for differentially expressed genes related to cholesterol processing provided a link to the ovarian cysts observed in both CGG-expressing lines. Early changes in transcriptome profiles led us to measure ovarian function in prepubertal females that revealed deficiencies in ovulatory responses to gonadotropins. These include impairments in cumulus expansion and resumption of oocyte meiosis, as well as reduced ovulated oocyte number. Cumulatively, we demonstrated the sufficiency of ectopically expressed CGG repeats to lead to ovarian insufficiency and that co-expression of CGG-RNA and FMRpolyG lead to premature cessation of breeding. However, the expression of CGG RNA-alone was sufficient to lead to ovarian dysfunction by impairing responses to hormonal stimulation.Keywords
Funding Information
- National Institutes of Health (P30CA125123)
- National Institute of General Medical Science’s (T32GM08307)
- National Institute of Neurological Disorders and Stroke (R01NS051630)
- Eunice Kennedy Shriver National Institute of Child Health & Human Development (R21HD084802)
This publication has 74 references indexed in Scilit:
- Sequestration of DROSHA and DGCR8 by Expanded CGG RNA Repeats Alters MicroRNA Processing in Fragile X-Associated Tremor/Ataxia SyndromeCell Reports, 2013
- Ovarian histopathological and ubiquitin‐immunophenotypic features in fragile X‐associated primary ovarian insufficiency: a study of five cases and selected controlsHistopathology, 2011
- Intra-individual stability over time of standardized anti-Mullerian hormone in FMR1 premutation carriersHuman Reproduction, 2011
- Non-ATG–initiated translation directed by microsatellite expansionsProceedings of the National Academy of Sciences, 2010
- Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patientsThe EMBO Journal, 2010
- Ectopic expression of CGG containing mRNA is neurotoxic in mammalsHuman Molecular Genetics, 2009
- Primary Ovarian InsufficiencyNew England Journal of Medicine, 2009
- RNA-Binding Proteins hnRNP A2/B1 and CUGBP1 Suppress Fragile X CGG Premutation Repeat-Induced Neurodegeneration in a Drosophila Model of FXTASNeuron, 2007
- Pur α Binds to rCGG Repeats and Modulates Repeat-Mediated Neurodegeneration in a Drosophila Model of Fragile X Tremor/Ataxia SyndromeNeuron, 2007
- Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutationExperimental Cell Research, 2007